Chlamydia muridarum Induces Pathology in the Female Upper Genital Tract via Distinct Mechanisms. 2019

Heze Yu, and Hui Lin, and Lingxiang Xie, and Lingli Tang, and Jianlin Chen, and Zhiguang Zhou, and Jiangdong Ni, and Guangming Zhong
Department of Orthopedics, The 2nd Xiangya Hospital, Central South University, Changsha, Hunan, China.

Sexually transmitted infection with Chlamydia trachomatis may lead to fibrotic blockage in women's upper genital tracts, resulting in tubal infertility. Intravaginal inoculation with C. muridarum readily induces fibrotic blockage or hydrosalpinx in mice and is used for investigating C. trachomatis pathogenicity. Using this model in combination with an antibody depletion approach, we confirmed CD4+ T cell-mediated protective immunity and a CD8+ T cell-dependent pathogenic mechanism during chlamydial infection in C57BL/6J mice. However, when mice genetically deficient in CD8+ T cells were evaluated, we found, surprisingly, that these mice were still able to develop robust hydrosalpinx following C. muridarum infection, both contradicting the observation made in C57BL/6J mice and suggesting a pathogenic mechanism that is independent of CD8+ T cells. We further found that depletion of CD4+ T cells from CD8+ T cell-deficient mice significantly reduced chlamydial induction of hydrosalpinx, indicating that CD4+ T cells became pathogenic in mice genetically deficient in CD8+ T cells. Since depletion of CD4+ T cells both promoted chlamydial infection and reduced chlamydial pathogenicity in CD8+ T cell-deficient mice, we propose that in the absence of CD8+ T cells, some CD4+ T cells may remain protective (as in C57BL/6J mice), while others may directly contribute to chlamydial pathogenicity. Thus, chlamydial pathogenicity can be mediated by distinct host mechanisms, depending upon host genetics and infection conditions. The CD8+ T cell-deficient mouse model may be useful for further investigating the mechanisms by which CD4+ T cells promote chlamydial pathogenicity.

UI MeSH Term Description Entries
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D002690 Chlamydia Infections Infections with bacteria of the genus CHLAMYDIA. Infections, Chlamydia,Chlamydia Infection,Infection, Chlamydia
D005260 Female Females
D005836 Genitalia, Female The female reproductive organs. The external organs include the VULVA; BARTHOLIN'S GLANDS; and CLITORIS. The internal organs include the VAGINA; UTERUS; OVARY; and FALLOPIAN TUBES. Accessory Sex Organs, Female,Sex Organs, Accessory, Female,Genital Organs, Female,Genitals, Female,Reproductive System, Female,Female Genital,Female Genital Organ,Female Genital Organs,Female Genitalia,Female Genitals,Female Reproductive System,Female Reproductive Systems,Genital Organ, Female,Genital, Female,Reproductive Systems, Female
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015496 CD4-Positive T-Lymphocytes A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes. T4 Cells,T4 Lymphocytes,CD4-Positive Lymphocytes,CD4 Positive T Lymphocytes,CD4-Positive Lymphocyte,CD4-Positive T-Lymphocyte,Lymphocyte, CD4-Positive,Lymphocytes, CD4-Positive,T-Lymphocyte, CD4-Positive,T-Lymphocytes, CD4-Positive,T4 Cell,T4 Lymphocyte
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D018414 CD8-Positive T-Lymphocytes A critical subpopulation of regulatory T-lymphocytes involved in MHC Class I-restricted interactions. They include both cytotoxic T-lymphocytes (T-LYMPHOCYTES, CYTOTOXIC) and CD8+ suppressor T-lymphocytes. Suppressor T-Lymphocytes, CD8-Positive,T8 Cells,T8 Lymphocytes,CD8-Positive Lymphocytes,Suppressor T-Cells, CD8-Positive,CD8 Positive Lymphocytes,CD8 Positive T Lymphocytes,CD8-Positive Lymphocyte,CD8-Positive Suppressor T-Cell,CD8-Positive Suppressor T-Cells,CD8-Positive Suppressor T-Lymphocyte,CD8-Positive Suppressor T-Lymphocytes,CD8-Positive T-Lymphocyte,Cell, T8,Cells, T8,Lymphocyte, CD8-Positive,Lymphocyte, T8,Lymphocytes, CD8-Positive,Lymphocytes, T8,Suppressor T Cells, CD8 Positive,Suppressor T Lymphocytes, CD8 Positive,Suppressor T-Cell, CD8-Positive,Suppressor T-Lymphocyte, CD8-Positive,T-Cell, CD8-Positive Suppressor,T-Cells, CD8-Positive Suppressor,T-Lymphocyte, CD8-Positive,T-Lymphocyte, CD8-Positive Suppressor,T-Lymphocytes, CD8-Positive,T-Lymphocytes, CD8-Positive Suppressor,T8 Cell,T8 Lymphocyte

Related Publications

Heze Yu, and Hui Lin, and Lingxiang Xie, and Lingli Tang, and Jianlin Chen, and Zhiguang Zhou, and Jiangdong Ni, and Guangming Zhong
April 2013, Pathogens and disease,
Heze Yu, and Hui Lin, and Lingxiang Xie, and Lingli Tang, and Jianlin Chen, and Zhiguang Zhou, and Jiangdong Ni, and Guangming Zhong
March 2012, Infection and immunity,
Heze Yu, and Hui Lin, and Lingxiang Xie, and Lingli Tang, and Jianlin Chen, and Zhiguang Zhou, and Jiangdong Ni, and Guangming Zhong
May 2017, Vaccine,
Heze Yu, and Hui Lin, and Lingxiang Xie, and Lingli Tang, and Jianlin Chen, and Zhiguang Zhou, and Jiangdong Ni, and Guangming Zhong
May 2021, Pathogens (Basel, Switzerland),
Heze Yu, and Hui Lin, and Lingxiang Xie, and Lingli Tang, and Jianlin Chen, and Zhiguang Zhou, and Jiangdong Ni, and Guangming Zhong
March 2010, Journal of immunology (Baltimore, Md. : 1950),
Heze Yu, and Hui Lin, and Lingxiang Xie, and Lingli Tang, and Jianlin Chen, and Zhiguang Zhou, and Jiangdong Ni, and Guangming Zhong
February 2016, Infection and immunity,
Heze Yu, and Hui Lin, and Lingxiang Xie, and Lingli Tang, and Jianlin Chen, and Zhiguang Zhou, and Jiangdong Ni, and Guangming Zhong
August 2019, Infection and immunity,
Heze Yu, and Hui Lin, and Lingxiang Xie, and Lingli Tang, and Jianlin Chen, and Zhiguang Zhou, and Jiangdong Ni, and Guangming Zhong
August 1986, Lancet (London, England),
Heze Yu, and Hui Lin, and Lingxiang Xie, and Lingli Tang, and Jianlin Chen, and Zhiguang Zhou, and Jiangdong Ni, and Guangming Zhong
February 2012, Journal of immunology (Baltimore, Md. : 1950),
Heze Yu, and Hui Lin, and Lingxiang Xie, and Lingli Tang, and Jianlin Chen, and Zhiguang Zhou, and Jiangdong Ni, and Guangming Zhong
February 1974, The British journal of venereal diseases,
Copied contents to your clipboard!